|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||127.68 - 129.79|
|52 Week Range||110.34 - 158.97|
|Beta (5Y Monthly)||0.70|
|PE Ratio (TTM)||33.71|
|Earnings Date||Oct. 28, 2021|
|Forward Dividend & Yield||1.52 (1.19%)|
|Ex-Dividend Date||Oct. 26, 2021|
|1y Target Est||152.00|
CRYSTAL LAKE, Ill., October 25, 2021--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today announced that its patented Cartridge Pump System (CPS), designed for the multidose delivery of preserved and non-preserved drug formulations, was recently reviewed by the U.S. FDA as the drug delivery device in the approval of Oyster Point Pharma’s TYRVAYA™ (varenicline solution) Nasal Spray 0.03 mg1, the first and only nas
AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AptarGroup, Inc. ( NYSE:ATR ) is about to trade ex-dividend in the next 4 days. Typically, the ex-dividend date is one...